Suppr超能文献

新型50:50聚乳酸-羟基乙酸共聚物造影剂的体外和体内声学响应比较

Comparison of in vitro and in vivo acoustic response of a novel 50:50 PLGA contrast agent.

作者信息

Wheatley Margaret A, Forsberg Flemming, Oum Kelleny, Ro Raymond, El-Sherif Dalia

机构信息

School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA 19104, USA.

出版信息

Ultrasonics. 2006 Nov;44(4):360-7. doi: 10.1016/j.ultras.2006.04.003. Epub 2006 May 8.

Abstract

A comparison between in vitro and in vivo experiments conducted to investigate the acoustic properties of a novel, 1.2 microm diameter poly(lactic-co-glycolic acid) (50:50) (PLGA) ultrasound contrast agent, the development of which was described previously by us, is presented. A pulse-echo setup was used to determine enhancement in vitro. Additional in vitro studies further characterized the hollow microcapsules, including resonance frequency from attenuation measurements (from 2.25 to 15 MHz) and temperature effects (25 degrees C vs. 37 degrees C). In vivo, four rabbits received intravenous injections of the agent (dose range: 0.005-0.13 ml/kg). Quantitative in vivo dose-responses were calculated off-line using spectral power analysis of audio Doppler signals acquired from a custom-made 10 MHz cuff transducer placed around the surgically exposed distal aorta. This frequency was chosen since the very shallow scanning depths encountered in rabbits, in particular for the cuff transducer placed directly around the vessel, necessitates the use of high frequency imaging devices with sufficient spatial resolution to enable meaningful measurements. For qualitative assessments, two rabbits were imaged pre- and post-contrast administration (dose: 0.1 ml/kg) in power Doppler mode. Significant acoustic enhancements (up to 24 dB) were reported both in vitro and in vivo. Moreover, the rabbits did not show any adverse side effects from multiple injections (>20) of the agent. Measured in vitro resonance frequency between 3.09 and 3.49 MHz was lower than predicted for a similar sized free bubble, potentially due to capsule wall structure. Minimal loss of signal (approximately 4 dB) was observed at 25 degrees C over 20 min of insonation at 5 MHz but at 37 degrees C the signal dropped close to base line within the first 5 min. This temperature sensitivity could be due to loss of capsule integrity (and hence loss of gas). Potential causes include increased hydrolysis or polymer softening and increased water uptake by the shell at temperatures closer to the glass transition temperature (T(g)).

摘要

本文介绍了一项对比实验,该实验对一种新型的、直径为1.2微米的聚乳酸-乙醇酸共聚物(50:50)(PLGA)超声造影剂的声学特性进行了体外和体内研究,我们之前已描述过该造影剂的研发情况。体外实验采用脉冲回波装置来测定增强效果。其他体外研究进一步对中空微胶囊进行了特性分析,包括通过衰减测量(2.25至15兆赫)确定共振频率以及温度影响(25摄氏度与37摄氏度)。在体内实验中,四只兔子接受了该造影剂的静脉注射(剂量范围:0.005 - 0.13毫升/千克)。使用从置于手术暴露的远端主动脉周围的定制10兆赫袖带换能器获取的音频多普勒信号的频谱功率分析,离线计算体内定量剂量反应。选择这个频率是因为兔子的扫描深度非常浅,特别是对于直接置于血管周围的袖带换能器,需要使用具有足够空间分辨率的高频成像设备才能进行有意义的测量。为了进行定性评估,两只兔子在注射造影剂前和注射后(剂量:0.1毫升/千克)采用功率多普勒模式成像。体外和体内实验均报告了显著的声学增强(高达24分贝)。此外,兔子多次注射(超过20次)该造影剂后未出现任何不良副作用。体外测量的共振频率在3.09至3.49兆赫之间,低于类似大小的自由气泡的预测值,这可能是由于胶囊壁结构所致。在5兆赫下照射20分钟,25摄氏度时信号损失最小(约4分贝),但在37摄氏度时,信号在最初5分钟内就降至接近基线水平。这种温度敏感性可能是由于胶囊完整性丧失(进而气体丧失)。潜在原因包括水解增加或聚合物软化以及在更接近玻璃化转变温度(T(g))时壳层对水的吸收增加。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验